Genetic Variations Within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a Large Italian Family Harbouring a Krit1/CCM1 Mutation

[1]  Yugang Wang,et al.  cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene , 1999, Science in China Series C: Life Sciences.

[2]  A. Louvi,et al.  Apoptotic Functions of PDCD10/CCM3, the Gene Mutated in Cerebral Cavernous Malformation 3 , 2009, Stroke.

[3]  U. Felbor,et al.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells , 2008, Human molecular genetics.

[4]  M. Lampugnani,et al.  Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke , 2008 .

[5]  O. Sürücü,et al.  Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in‐frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex , 2008, Human mutation.

[6]  U. Felbor,et al.  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations , 2007, Neurogenetics.

[7]  L. Tassi,et al.  Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation. , 2007, Archives of neurology.

[8]  Xiao Han,et al.  PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. , 2007, Molecular biology of the cell.

[9]  D. Marchuk,et al.  CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. , 2005, Human molecular genetics.

[10]  M. Clanet,et al.  Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.

[11]  P. Frérebeau,et al.  Mutations within the MGC4607 gene cause cerebral cavernous malformations. , 2004, American journal of human genetics.

[12]  C. Liquori,et al.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.

[13]  M. Dell'Acqua,et al.  Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock , 2003, Nature Cell Biology.

[14]  A. Joutel,et al.  Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations , 2002, European Journal of Human Genetics.

[15]  D. Verlaan,et al.  Cerebral cavernous malformations: Mutations in Krit1 , 2002, Neurology.

[16]  Erica A Golemis,et al.  KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. , 2002, Human molecular genetics.

[17]  D. Chang,et al.  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. , 2001, Human molecular genetics.

[18]  L. Brunereau,et al.  Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families , 1998, The Lancet.

[19]  R. Scott,et al.  Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. , 1998, Human molecular genetics.

[20]  I. Awad,et al.  Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Weber,et al.  A gene responsible for cavernous malformations of the brain maps to chromosome 7q. , 1995, Human molecular genetics.

[22]  R F Spetzler,et al.  The natural history of familial cavernous malformations: results of an ongoing study. , 1994, Journal of neurosurgery.